Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.59 |
| ▸ | CES1 | P23141 | 3/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1581395 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL2761831 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL11494540 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL18045476 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL19642160 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL5968483 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL815938 | 1.00 | CES2 (0.59) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL816636 | 0.98 | CES2 (0.58) | CES2CES1PTGS2NAAAL3MBTL1 | |
| SCHEMBL820442 | 0.91 | PTGS2 (0.59) | CES2CES1PTGS2NAAA | |
| SCHEMBL3281895 | 0.84 | L3MBTL1 (0.44) | CES2CES1PTGS2L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-55007218-A | — | — | None | — | — | JP | disclosed |
| CN-118241039-A | Extractant for extracting lithium from alkaline lithium-containing solution, and preparation method and application thereof | 中国科学院过程工程研究所 | 2024-06-25 | — | — | CN | disclosed |
| WO-2009076722-A1 | METHOD OF PROTECTING A SURFACE FROM BIOLOGICAL FOULING | THE UNIVERSITY OF MELBOURNE (AU) | 2009-06-25 | — | — | WO | disclosed |
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-12-07 | — | — | US | disclosed |
| EP-0495777-A4 | STRUCTURAL AGGREGATE PIGMENTS | — | 1992-09-30 | — | — | EP | disclosed |
| EP-0495777-A1 | STRUCTURAL AGGREGATE PIGMENTS | INDUSTRIAL PROGRESS, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
| WO-1991005604-A1 | STRUCTURAL AGGREGATE PIGMENTS | INDUSTRIAL PROGRESS, INC. (US) | 1991-05-02 | — | — | WO | disclosed |
| CN-1050889-A | STRUCTURAL AGGREGATE PIGMENTS | IND PROGRESS INC (US) | 1991-04-24 | — | — | CN | disclosed |
| CN-1050888-A | STRUCTURAL AGGREGATE PIGMENTS | IND PROGRESS INC (US) | 1991-04-24 | — | — | CN | disclosed |
| JP-S557218-A | STABLE QUATERNARY AMMONIUM SALT COMPOSITION | KAO CORP | 1980-01-19 | — | — | JP | disclosed |
| US-3981937-A | BY REACTION WITH ALKALI METAL HYDROXIDES OR ALKALINE EARTH METAL HYDROXIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | ENPP1, ENPP3, SMPD1 | CES2 56/4885CES1 82/4885PTGS2 2383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.